Author of the publication

Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism

, , , , , , , , , and . Cell Death & Differentiation, 27 (8): 2417--2432 (February 2020)
DOI: 10.1038/s41418-020-0512-5

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism, , , , , , , , , and . Cell Death & Differentiation, 27 (8): 2417--2432 (February 2020)Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism, , , , , , , , , and . Cell Death and Differentiation, (2020)Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide, , , , , , , , , and 1 other author(s). Journal of Investigative Dermatology, 129 (6): 1500--1515 (June 2009)The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells, , , , , , , , , and 8 other author(s). Journal of Investigative Dermatology, 131 (2): 468--479 (2011)Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells, , , , , , , and . Journal of Investigative Dermatology, 128 (8): 2013--2023 (August 2008)